articles This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. June 2022 Molecules of the Month Runners-Up Readers have been asking for more molecules, so we started a new feature that highlights a few of the molecules… Article 4 months ago ● 7 mins read HighlightsPremium Molecules of the Month – June 2022 A SETD2 inhibitor with Fast Track Status for hematological malignancies, a CNS-penetrating, ATP-competitive LRRK2 inhibitor for Parkinson’s disease, and an… Article 4 months ago ● 1 min read Molecules of the MonthPremium Beginning with the End in Mind: Five Minutes with a Commercial Leader Product development is unique in biopharma in the degree of separation between product developers (R&D scientists) and end users (patients… Article 4 months ago ● 10 mins read Perspectives Biotechnology-Based Molecules in Oncology: 2021 IPO Review Pt. IV This short article and poster summary takes a deeper look into the 2021 IPOs for biotechnology-based therapeutics being developed by… Article 4 months ago ● 5 mins read MinireviewPremium Small Molecules in Oncology from Emerging Companies: 2021’s IPOs Pt. III This article is Part 3 of a review series covering all of the initial public offerings for the biotech and… Article 5 months ago ● 5 mins read MinireviewPremium Literature Highlights from April and May 2022 There’s so many interesting new publications that don’t necessarily feature key molecules, but are helpful for drug hunters to know… Article 5 months ago ● 6 mins read HighlightsPremium Pages: 12345678910111213141516171819Load More
